ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0028

Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients

Valerie Aloush1, Avital Gurfinkel2, Noam Shachar3, Jacob Ablin1 and Odelia Elkana4, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College TelAviv- Jaffa, Tel Aviv, Israel, 3Acamedic College Tel Aviv- Jaffa, Tel Aviv, Israel, 4Academic College Tel Aviv Jaffa, Tel Aviv, Israel

Meeting: ACR Convergence 2020

Keywords: COVID-19, fibromyalgia, mental health, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia is a chronic pain disorder, characterized by abnormal pain processing in the central nervous system. Acute or chronic stress may trigger or aggravate symptoms.  We aimed to evaluate the physical and mental health of fibromyalgia (FMS) patients during the COVID 19 outbreak, and to identify related protective and risk factors.

Methods: An online survey was published via social media dedicated to fibromyalgia patients (FMS associations) in May 2020, following two months of lockdown and social distancing due to the COVID 19 outbreak. The survey included questionnaires regarding demographic and socio-economic characteristics, access to medical services, anxiety, depression, life approach, coping strategies and perception of social support. Fibromyalgia severity was assessed using the widespread pain index (WPI) and symptoms severity scale (SSS), insomnia severity index (ISI) and patient global assessment

Results: A total of 262 fibromyalgia patients were recruited of which 233 (90% women, median age 46.1 years) completed the entire study questionnaire and thus were included in the analysis. During the lockdown, 43% of patients stopped contact with their treating physician and 98% were forced to discontinue complementary – alternative treatments. On the other hand, all patients undergoing psychotherapy continued online follow-up. Among the 41% of responders who had been treated with medical cannabis, 30% were forced to discontinue treatment due to logistic difficulties and this was associated with significantly higher scores of WPI/SSS compared with patients who continued cannabis treatment (p=0.024). Higher levels of anxiety and depression were significantly correlated with higher levels of pain, sleep disorders and subjective perception of deterioration (p=0.00). Higher scores of social support and positive life approach were correlated with less anxiety and depression (p< 0.01), lower levels of pain (p< 0.05) and less sleep disturbances (p< 0.01). Avoidant coping style such as denial and behavioral disengagement was strongly associated to higher levels of pain, sleep disturbances, anxiety, depression and subjective perception of worsening (p< 0.01).

Conclusion: The current study documented high levels of anxiety, depression, sleep disturbances and pain among fibromyalgia patients during the COVID-19 outbreak, with a large proportion of patients reporting a worsening of symptoms during this period. While general stress associated with the pandemic is an obvious possible culprit for this course, additional factors such as difficulty in accessing medical and complementary treatments, as well as specific medications such as medical cannabis, may play a central role. Protective factors such as social support and a positive life approach appear to be particularly important.


Disclosure: V. Aloush, None; A. Gurfinkel, None; N. Shachar, None; J. Ablin, None; O. Elkana, None.

To cite this abstract in AMA style:

Aloush V, Gurfinkel A, Shachar N, Ablin J, Elkana O. Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/pain-in-the-time-of-corona-impact-of-covid-19-outbreak-on-fibromyalgia-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-in-the-time-of-corona-impact-of-covid-19-outbreak-on-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology